ch.oddb.org
 
Apotheken | Doctor | Drugs | Hospital | Interactions | MiGeL | Registration owner | Services
Information for professionals for Mycostatin® Vaginalcreme:Sanofi-Synthélabo (Suisse) SA
Complete information for professionalsDDDPrint 
Galenic Form / Therapeutic GroupComposition.EffectsPharm.kinetikIndication.UsageRestrictions.Unwanted effects
Interactions.OverdoseOther adviceSwissmedic-Nr.Last update of information 
G01AA01 - NystatinATC-DDD Version 2016. Source: WHO
G - Genito Urinary System and Sex Hormones
 
G01 - Gynecological Antiinfectives and Antiseptics

This group comprises gynecological antiinfectives and antiseptics mainly for local use. See also:
J - Antiinfectives for systemic use
D06 - Antibiotics and chemotherapeutics for dermatological use
P01AB - Nitroimidazole derivatives

The DDDs are based on the treatment of vaginal infections.

G01A - Antiinfectives and Antiseptics, Excl. Combinations with Corticosteroids

This group comprises preparations, mainly for local use.
Combinations with corticosteroids, see G01B.
Antivirals for topical use, including gynecological use, such as podophyllotoxin, are classified in D06 - Antibiotics and chemotherapeutics for dermatological use.

G01AA - Antibiotics

Nystatin in combination with nifuratel is classified in G01AA51.

G01AA01 - Nystatin
DoseRoute of administrationNote
 V 
2025 ©ywesee GmbH
Settings | Help | FAQ | Login | Contact | Home